4th Quarter - Report
PURDUE PHARMA, LP for PURDUE PHARMA LP
Firm
Client
Income
—
Expenses
$209,625
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN KONKA New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.